Developing and Expanding Deceased Organ Donation to Its Maximum Therapeutic Potential: An Actionable Global Challenge From the 2023 Santander Summit
Dale Gardiner(NHS Blood and Transplant), Francis L. Delmonico(Massachusetts Medical Society), Michael Spiro(The London College), Martín Torres, Beatriz Domínguez‐Gil(Universidad de Zaragoza), Helen Opdam(BirdLife Australia), Matthew Cooper(Medical College of Wisconsin), Ali Abdul Kareem Al Obaidli(Ministry of Health), Amy D. Waterman(Houston Methodist), Andrew McGee(Queensland University of Technology), Sam D. Shemie(Montreal Children's Hospital), Sanjay Nagral(Jaslok Hospital), Francesco Procaccio(Istituto Superiore di Sanità), Eduardo Miñambres(Universidad de Cantabria), David Thomson(University of Cape Town), Krista L. Lentine(Saint Louis University Hospital)
Cited by 20
Related Papers
Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies: A Scientific Statement From the American Heart Association
|Circulation|2019|1.3k
Chronic Kidney Disease and Coronary Artery Disease
|Journal of the American College of Cardiology|2019|716
Kidney Transplantation as Primary Therapy for End-Stage Renal Disease
|Clinical Journal of the American Society of Nephrology|2008|623
Use of Monoclonal Antibodies to T-Cell Subsets for Immunologic Monitoring and Treatment in Recipients of Renal Allografts
|New England Journal of Medicine|1981|513
Acute Humoral Rejection in Kidney Transplantation
|Journal of the American Society of Nephrology|2002|491